Epidemiology

U.S. Sees Higher Gonorrhea Drug Resistance

Published in Medical Letter on the CDC and FDA, June 8th, 1998

Domestic cases of gonorrhea have shown increased resistance to one of the remaining drugs still effective in treating the sexually transmitted disease, U.S. health officials said.

The U.S. Centers for Disease Control and Prevention (CDC) said two cases of gonorrhea identified in San Diego, California, in 1997 showed the highest level of fluoroquinolone resistance ever reported in the United States.

Strains of gonorrhea resistant to the class of antibiotics known as flouroquinolones are already well-established in Hong Kong, Japan, and the Philippines, the CDC said.

The two cases in California both involved the same strain of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1998-06-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry